EX-99.3 5 ex_764554.htm EXHIBIT 99.3 ex_764554.htm

Exhibit 99.3

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

On October 28, 2024, Standex International Corporation (“Standex” or the “Company”), acquired 100% of the outstanding membership interests of Amran, LLC, a Texas limited liability company (“Amran”) for consideration including i) a cash payment in the amount of $153.3 million and ii) 152,299 shares of Standex common stock.

 

Also on October 28, 2024 and simultaneous with its acquisition of Amran, Standex, through its wholly owned Singaporean subsidiary, Mold-Tech Singapore PTE LTD (“Mold-Tech Singapore”), acquired 90.1% of the capital stock of Narayan Powertech Private Limited, a private company incorporated under the laws of India (“Narayan”) for a cash payment in the amount of $261.6 million.

 

The acquisitions of Amran and Narayan (together, “Amran/Narayan Group Acquisition”) were determined to constitute a business combination in accordance with Accounting Standards Codification 805, Business Combinations (“ASC 805”) under generally accepted accounting principles in the United States (“U.S. GAAP”).

 

The unaudited pro forma condensed combined financial statements have been prepared in accordance with Article 11 of Regulation S-X under the Securities Act of 1933, as amended by the final rule, Release No.33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses,” and have been adjusted to include estimated transaction accounting adjustments which give effect to the Amran/Narayan Group Acquisition and the application of the acquisition method of accounting under U.S. GAAP. Under the acquisition method of accounting, the preliminary purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with any excess purchase price allocated to goodwill. The pro forma adjustments are based on preliminary estimates and currently available information and assumptions that Standex’s management believes are reasonable. The notes to the unaudited pro forma condensed combined financial statements provide a discussion of how such adjustments were derived and presented in the unaudited pro forma condensed combined financial statements. Changes in facts and circumstances or discovery of new information may result in revised estimates. Actual results and valuations may differ materially from the assumptions within the accompanying unaudited pro forma condensed combined financial information.

 

The unaudited pro forma condensed combined financial statements and related notes as of and for the year ended June 30, 2024 have been derived from, and should be read in conjunction with:

 

 

(i)

the historical audited consolidated financial statements of Standex and accompanying notes included in Standex’s Annual Report on Form 10-K for the year ended June 30, 2024, incorporated by reference;

 

 

(ii)

the historical audited combined financial statements of the Amran/Narayan Group and accompanying notes for the year ended December 31, 2023, appearing within this Current Report on Form 8-K as Exhibit 99.1; and

 

 

(iii)

the historical unaudited condensed combined interim financial statements of the Amran/Narayan Group and accompanying notes for the six months ended June 30, 2024, appearing within this Current Report on Form 8-K as Exhibit 99.2.

 

The accompanying unaudited pro forma condensed combined statements of operations for the year ended June 30, 2024 combine the historical consolidated statements of operations for Standex and the historical consolidated statements of operations for the Amran/Narayan Group for the same period. As the Amran/Narayan Group’s fiscal year end differed from Standex’s, the consolidated statement of operations was derived from subtracting the six months ended June 30, 2023 from the year ended December 31, 2023 and adding the six months ended June 30, 2024 to form a full year ended June 30, 2024.

 

The unaudited pro forma condensed combined balance sheet as of June 30, 2024 gives effect to the Amran/Narayan Group Acquisition as if it occurred on June 30, 2024. The unaudited pro forma condensed combined statement of operations for the year ended June 30, 2024 gives effect to the Amran/Narayan Group Acquisition as if it occurred on July 1, 2023.

 

The unaudited pro forma condensed combined financial statements are for illustrative and informational purposes only and are not intended to represent what Standex’s results of operations or financial position would have been had the Amran/Narayan Group Acquisition occurred on the dates indicated, or what they will be for any future periods. The unaudited pro forma condensed combined financial statements do not reflect the realization of any expected cost savings, other synergies as a result of the acquisition, or integration costs. 

 

1

 

STANDEX INTERNATIONAL CORPORATION

Unaudited Pro Forma Condensed Combined Balance Sheet

As of June 30, 2024

(In thousands, except per share data)

 

   

Standex
(Historical)

   

The Amran/

Narayan

Group

Operations
(Adjusted

Historical)
(Note 3)

   

Transaction

Accounting

Adjustments
(Note 4)

 

Note

 

Pro Forma

 

ASSETS

                                 

Current assets:

                                 

Cash and cash equivalents

  $ 154,203     $ 27,128     $ (166,774 )

4(a)

  $ 14,557  

Accounts receivable, net

    121,365       24,582       -         145,947  

Inventories

    87,106       11,885       1,555  

4(b)

    100,546  

Prepaid expenses and other current assets

    22,028       4,191       9,500  

4(c)

    35,719  

Contract assets

    45,393       -       -         45,393  

Total current assets

    430,095       67,786       (155,719 )       342,162  
                                   

Property, plant and equipment, net

    134,963       1,066       -         136,029  

Intangible assets, net

    78,673       -       135,000  

4(d)

    213,673  

Goodwill

    281,283       -       283,991  

4(e)

    565,274  

Deferred tax assets, net

    17,450       257       -         17,707  

Operating lease right-of-use asset

    37,078       2,970       -         40,048  

Other non-current assets

    25,515       442       -         25,957  

Total non-current assets

    574,962       4,735       418,991         998,688  
                                   

Total assets

  $ 1,005,057     $ 72,521     $ 263,272       $ 1,340,850  
                                   

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS EQUITY

                           

Current liabilities:

                                 

Accounts payable

  $ 63,364     $ 4,915     $ -       $ 68,279  

Accrued liabilities

    56,698       2,794       12,794  

4(f)

    72,286  

Income tax payable

    7,503       961       -         8,464  

Current debt

    -       -       248,049  

4(g)

    248,049  

Total current liabilities

    127,565       8,670       260,843         397,078  
                                   

Long-term debt

    148,876       -       -         148,876  

Operating lease liabilities, non-current

    30,725       2,305       -         33,030  

Deferred tax liabilities

    -       -       21,309  

4(h)

    21,309  

Accrued pension and other non-current liabilities

    76,388       -       -         76,388  

Total non-current liabilities

    255,989       2,305       21,309         279,603  
                                   

Contingencies

                                 
                                   

Mezzanine equity:

                                 

Redeemable noncontrolling interest

    -       -       28,142  

4(i)

    28,142  
                                   

Stockholders' equity:

                                 

Common stock, par value $1.50 per share

    41,976       -       -         41,976  

Additional paid-in capital

    106,193       -       23,247  

4(j)

    129,440  

Retained earnings

    1,086,277       61,846       (74,640 )

4(k)

    1,073,483  

Accumulated other comprehensive (loss) income

    (182,956 )     (300 )     300  

4(l)

    (182,956 )

Treasury shares

    (429,987 )     -       4,071  

4(m)

    (425,916 )

Total stockholders’ equity

    621,503       61,546       (47,022 )       636,027  
                                   

Total liabilities, mezzanine equity and stockholders' equity

  $ 1,005,057     $ 72,521     $ 263,272       $ 1,340,850  

 

 

See accompanying notes to the unaudited condensed combined pro forma financial information.

 

2

 

STANDEX INTERNATIONAL CORPORATION

 

Unaudited Pro Forma Condensed Combined Statement of Operations

12 Months Ended June 30, 2024

(In thousands, except per share data)

 

   

Standex
(Historical)

   

The Amran/

Narayan Group

Operations
(Historical)

   

Transaction

Accounting

Adjustments
(Note 5)

 

Note

 

Pro Forma

 

Net sales

  $ 720,635     $ 94,217     $ -       $ 814,852  

Cost of sales

    (438,634 )     (44,561 )     (11,055 )

5(a)

    (494,250 )

Gross profit

    282,001       49,656       (11,055 )       320,602  
                      -         -  

Selling, general, and administrative expenses

    169,599       10,408       8,858  

5(b)

    188,865  

Restructuring costs

    8,206       -       -         8,206  

(Gain) loss on sale of business

    (274 )     -       -         (274 )

Acquisition related costs

    2,622       -       12,794  

5(c)

    15,416  

Other operating (income) expense

    110       -       -         110  

Income (loss) from operations

    101,738       39,248       (32,707 )       108,279  
                                   

Interest expense

    4,544       -       21,188  

5(d)

    25,732  

Other non-operating (income) expense, net

    2,071       (845 )     -         1,226  

Income (loss) from continuing operations before income taxes

    95,123       40,093       (53,895 )       81,321  

(Provision for) benefit from income taxes

    (21,532 )     (8,175 )     6,444  

5(e)

    (23,263 )

Net income (loss) from continuing operations before redeemable noncontrolling interest

    73,591       31,918       (47,451 )       58,058  

Net income (loss) from continuing operations attributable to redeemable noncontrolling interest

    -       -       (55 )

5(f)

    (55 )

Net income (loss) from continuing operations attributable to Standex

  $ 73,591     $ 31,918     $ (47,396 )     $ 58,113  
                                   
                                   

Earnings per share of common stock

                                 

Basic

  $ 6.26                       $ 4.87  

Diluted

  $ 6.18                       $ 4.82  
                                   

Weighted average shares of common stock outstanding

                                 

Basic

    11,763               152  

5(g)

    11,915  

Diluted

    11,904               152  

5(g)

    12,056  

 

 

See accompanying notes to the unaudited condensed combined pro forma financial information.

 

3

 

STANDEX INTERNATIONAL CORPORATION

 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

Note 1 Description of the Amran/Narayan Group Acquisition

 

On October 28, 2024, Standex International Corporation (“Standex” or the “Company”), acquired 100% of the outstanding membership interests of Amran, LLC (“Amran”), a Texas limited liability company from the Amran membership interest holders (“Amran Sellers”) for consideration including: i) a cash payment in the amount of $153.3 million; and ii) 152,299 shares of Standex common stock, subject to customary closing adjustments (the “Amran Acquisition”.

 

Also on October 28, 2024 and simultaneous with its acquisition of Amran, Standex, through its wholly owned Singaporean subsidiary, Mold-Tech Singapore PTE LTD (“Mold-Tech Singapore”), acquired 90.1% of the capital stock of Narayan Powertech Private Limited and its joint venture with Amran, Amtran Magnetics Pvt. Ltd. (“Amtran”) each a private company incorporated under the laws of India (“Narayan”, and together with Amran and the parties’ joint venture, Amtran, the “Amran/Narayan Group”) from the Narayan capital stockholders (“Narayan Sellers”) for a cash payment of in the amount of $261.6 million, subject to customary closing adjustments (the “Narayan Acquisition”, and together with the Amran Acquisition, the “Amran/Narayan Group Acquisition”). Subject to receipt of regulatory approval from the Reserve Bank of India (“RBI”), Mold-Tech Singapore will acquire the remaining 9.90% of the capital stock of Narayan in a second closing, in consideration for shares of Standex common stock (the “Narayan Issued Securities”), reflecting the equivalent of $27.9 million, divided by the lesser of the closing price and the average closing price of Standex’s common stock measured over a 30-day trading period preceding such second closing date (the “Share Swap”).

 

Simultaneously with the execution of the Narayan Acquisition, Standex, Mold-Tech Singapore and certain of the stockholders of Narayan named therein (the “Narayan Minority Shareholders”) entered into a Shareholders’ Agreement dated as of October 28, 2024 (the “Shareholders’ Agreement”). The Shareholders’ Agreement provides that in the event RBI does not provide its approval for the Share Swap by October 28, 2025, then the remaining 9.90% of the outstanding capital stock of Narayan shall be subject to put and call options which may be exercised from time to time in accordance with schedules set forth in the Shareholders’ Agreement. The purchase price for the exercise of any such put or call option shall be based on the greater of (a) the fair market value of the securities of Narayan as of the October 28, 2024 and (b) Narayan’s valuation based on a formula using Narayan’s adjusted EBITDA for the twelve months prior to exercise of any such put and call option. The Shareholders’ Agreement also includes certain minority shareholder rights provided to the Narayan Minority Shareholders, including preemptive rights, rights to appoint directors, protective provisions for certain matters and tag-along rights. The Narayan Shareholders’ Agreement terminates automatically upon consummation of the Share Swap or at such time as all of the Narayan Minority Shareholders and their permitted transferees no longer hold any capital stock of Narayan.

 

Note 2 Basis of Presentation

 

The Amran/Narayan Group Acquisition is being accounted for as a business combination using the acquisition method of accounting under US GAAP, in accordance with the provisions of ASC 805, Business Combinations, (“ASC 805”) which requires assets acquired and liabilities assumed to be recorded at their acquisition date fair value. ASC 820, Fair Value Measurements, defines the term “fair value” as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” Fair value measurements can be highly subjective, and it is possible the application of reasonable judgement could develop different assumptions resulting in a range of alternative estimates using the same facts and circumstances.

 

Standex and the Amran/Narayan Group’s historical financial statements were prepared in accordance with US GAAP. Based on an analysis of Standex and the Amran/Narayan Group’s significant accounting policies, the Company has not identified any material differences in accounting policies that would have an impact on the unaudited pro forma condensed combined financial statements. As a result, the unaudited pro forma condensed combined financial statements do not assume any differences in accounting policies.

 

4

 

The pro forma adjustments presented in this unaudited pro forma condensed combined financial information represent management’s estimates based on information available as of the date of this Form 8-K and such estimates are subject to revision as further information is obtained. Accordingly, the pro forma adjustments for the Amran/Narayan Group Acquisition are preliminary and subject to further adjustment as additional information becomes available and the various analyses and other valuations are performed. Any adjustments may have a significant effect on total assets, total liabilities, total equity, operating expenses, and depreciation and amortization expenses, and such results may be significant.

 

The assumptions underlying the pro forma adjustments are described in the accompanying notes to this unaudited pro forma condensed combined financial information.

 

The unaudited pro forma condensed combined financial information may not be indicative of Standex’s future performance and does not necessarily reflect what Standex’s financial position and results of operations would have been had these transactions occurred at the beginning of the period presented.

 

Further, the unaudited pro forma condensed combined financial information does not purport to project the future operating results or financial position of Standex following the completion of the Amran/Narayan Group Acquisition. Additionally, the unaudited pro forma condensed combined financial information does not reflect any revenue enhancements, anticipated synergies, operating efficiencies, or cost savings that may be achieved related to the Amran/Narayan Group Acquisition, nor does it reflect any costs or expenditures that may be required to achieve any possible synergies.

 

Standex will finalize the accounting for the acquisition as soon as practicable within the measurement period, but in no event later than one year from October 28, 2024, in accordance with ASC 805.

 

Note 3 Conforming Presentation Adjustments to the Amran/Narayan Group Historical Reported Financial Data

 

In preparing the pro forma condensed combined financial information, the following adjustments were made to the Amran/Narayan Group’s historical financial statements to conform to the presentation of Standex’ historical financial statements: 

 

Presentation in Historical Financial

Statements

Presentation in Unaudited Pro Forma

Condensed Combined Financial Statements

 

Historical Amran/

Narayan Group

Before Adjustment

   

Adjustment

 

Note

 

Historical

Amran/Narayan

Group as

Adjusted

 

Cash and cash equivalents

Cash and cash equivalents

  $ 27,128     $ -       $ 27,128  

Trade accounts receivable, net

Trade accounts receivable, net

    24,582       -         24,582  

Inventories

Inventories

    11,885       -         11,885  

Prepaids expenses and other current assets

Prepaids expenses and other current assets

    4,191       -         4,191  

Property and equipment, net

Property and equipment, net

    1,066       -         1,066  

Operating lease right-of-use assets, net

Operating lease right-of-use assets, net

    1,567       1,403   (a)     2,970  
Operating lease right-of-use assets, net - related party Operating lease right-of-use assets, net     1,403       (1,403 ) (a)     -  

Deferred tax assets, net

Deferred tax assets

    257       -         257  

Other long-term assets

Other non-current assets

    442       -         442  
Line of credit Accrued liabilities     630       (630 ) (b)     -  

Accounts payable

Accounts payable

    4,915       -         4,915  

Accrued liabilities

Accrued liabilities

    1,206       1,588  

(b)-(f)

    2,794  

Contract liabilities

Accrued liabilities

    146       (146 )

(c)

    -  
Operating lease current liabilities Accrued liabilities     410       (410 ) (d)     -  
Operating lease current liabilities - related party Accrued liabilities     274       (274 ) (e)     -  
Income taxes payable Income taxes payable     961       -         961  

Other current liabilities

Accrued liabilities

    128       (128 )

(f)

    -  

Operating lease long-term liabilities

Operating lease liabilities non-current     1,157       1,148  

(g)

    -  

Operating lease liabilities long-term liabilities - related party

Operating lease liabilities non-current

    1,148       (1,148 ) (g)     2,305  
Net investment Retained earnings     3,459       (3,459 ) (h)     -  

Retained earnings

Retained earnings     58,387       3,459   (h)     61,846  

Accumulated other comprehensive loss

Accumulated other comprehensive loss

    (300 )     -         (300 )

 

(a) Represents an adjustment to reclassify $1.4 million of Operating lease right-of-use assets, net – related party to Operating lease right-of-use assets, net

(b) Represents an adjustment to reclassify $0.6 million of Line of credit to Accrued liabilities

(c) Represents an adjustment to reclassify $0.1 million of Contract liabilities to Accrued liabilities

(d) Represents an adjustment to reclassify $0.4 million of Operating lease current liabilities to Accrued liabilities

(e) Represents an adjustment to reclassify $0.3 million of Operating lease current liabilities – related party to Accrued liabilities

(f) Represents an adjustment to reclassify $0.1 million of Other current liabilities to Accrued liabilities

(g) Represents an adjustment to reclassify $1.1 million of Operating lease long-term liabilities – related party to Operating lease liabilities, non-current

(h) Represents an adjustment to reclassify $3.5 million of Net investment to Retained earnings

 

5

 

Note 4 Amran/Narayan Group Acquisition and Acquisition Accounting Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet

 

Preliminary Purchase Price Allocation

 

The following preliminary purchase price allocation has been used to prepare pro forma adjustments in the unaudited pro forma condensed combined balance sheet.

 

Fair value of consideration given:

 

Amount
(in thousands)

 
         

Cash(1)(2)

  $ 414,823  

Equity(3)

    27,318  

Total fair value of consideration given

  $ 442,141  
         

Identifiable assets acquired and liabilities assumed:

       
         

Cash

  $ 27,128  

Accounts receivable

    24,582  

Inventories(4)

    13,440  

Prepaid expenses and other current assets(5)

    13,691  

Property, plant, and equipment

    1,066  

Intangible assets(6)

    135,000  

Goodwill(7)

    283,991  

Other non-current assets

    3,669  

Deferred tax liability(8)

    (21,309 )

Other liabilities assumed

    (10,975 )

Total identifiable assets acquired and liabilities assumed

    470,283  
         

Noncontrolling interest(9)

    (28,142 )
         

Total identifiable assets acquired and liabilities assumed including NCI

  $ 442,141  

 

(1)

The cash consideration was funded utilizing cash on hand of $414.8 million and proceeds borrowed under a Term Loan Credit Agreement of $250.0 million, offset by deferred financing costs of $2.0 million. See pro forma adjustment (a) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to cash and cash equivalents.

 

(2)

The total cash consideration transferred is subject to customary closing adjustments.

 

(3)

Represents the fair value of 152,299 shares of Standex common stock issued to the Amran sellers.

 

(4)

See pro forma adjustment (b) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to inventories.

 

(5)

See pro forma adjustment (c) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to other assets.

 

(6)

See pro forma adjustment (d) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to intangible assets.

 

(7)

See pro forma adjustment (e) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to goodwill.

 

6

 

(8)

See pro forma adjustment (h) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to deferred tax liabilities.

 

(9)

See pro forma adjustment (i) below for adjustments to the unaudited pro forma condensed combined balance sheet relating to noncontrolling interest.

 

 

Pro Forma Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet

 

(a)

Represents the cash consideration paid to the Amran/Narayan Group sellers partially offset by the cash received from the Term Loan Credit Agreement as follows:

 

Cash paid to Seller

  $ (414,823 )

Cash received from Term Loan Credit Agreement

    248,049  

Total pro forma adjustment to cash and cash equivalents

  $ (166,774 )

 

(b)

Represents the purchase accounting adjustment to increase the value of the inventories to the estimated selling price adjusted for (1) costs of the selling effort and (2) a reasonable profit allowance for the selling effort of the Company.

 

(c)

Represents the purchase accounting adjustment to increase the other assets to their fair values. As part of the preliminary valuation analysis, the Company identified backlog assets. The fair value of identifiable backlog assets is determined primarily using the “income approach,” which requires a forecast of all of the expected future cash flows.

 

(d)

Represents the purchase accounting adjustment to increase the intangible assets to their fair values. As part of the preliminary valuation analysis, the Company identified intangible assets, including trade names and customer relationships. The fair value of identifiable intangible assets is determined primarily using the “income approach,” which requires a forecast of all of the expected future cash flows.

 

(e)

Represents the purchase accounting adjustment to goodwill based on the acquisition method.

 

(f)

Represents the estimated transaction costs associated with the Amran/Narayan Group acquisition incurred by Standex subsequent to June 30, 2024.

 

(g)

Represents a $250 million Term Loan Credit Agreement to finance the cash consideration portion of total consideration, less $2.0 million in debt issuance costs incurred to obtain the Term Loan Credit Agreement. This obligation is classified as current debt based on its term of one year. The Company replaced this loan with long-term financing on December 6, 2024.

 

(h)

Represents the purchase accounting adjustment to deferred tax liability based on the acquisition method.

 

(i)

Establishes noncontrolling interest for the 9.9% of capital stock of Narayan that the Company did not acquire as described in Note 1. The Company has preliminarily concluded the noncontrolling interest is redeemable and does not meet the classification requirements for permanent equity. The redeemable noncontrolling interest amount represents the fair value based on the acquisition method of accounting.

 

(j)

Represents adjustments to additional paid-in capital for the $27,318 fair value, less the treasury stock cost of $4,071 for the 152,999 shares of Standex common stock issued to the Amran sellers.

 

(k)

Represents adjustments to retained earnings to eliminate the historical $61,846 retained earnings of the Amran/Narayan Group plus the estimated transaction costs associated with the Amran/Narayan Group acquisition incurred by Standex subsequent to June 30, 2024 described in note (f) above.

 

(l)

Represents an adjustment to stockholders’ equity to eliminate the historical accumulated other comprehensive loss of the Amran/Narayan Group

 

(m)

Represents the treasury stock cost of the 152,999 shares of Standex common stock issued to the Amran sellers.

 

7

 

Note 5 Acquisition Accounting Adjustments to Unaudited Pro Forma Condensed Combined Statement of Operations

 

(a)

Represents the increase in cost of sales of $1.6 million due to the sale of inventories that had been adjusted to fair value in accordance with the acquisition method plus $9.5 million of amortization expense associated with other current assets. The following table summarized the estimated fair value of other current assets and its estimated useful life and uses an accelerated method of amortization based on the estimated cash flows used in the valuation.

 

   

Estimated fair

value

   

Estimated useful

life in years

   

Twelve months ended

June 30, 2024

amortization expense

 

Back log

  $ 9,500       1     $ 9,500  

 

(b)

The following table summarizes the estimated fair values of the Amran/Narayan Group’s identifiable intangible assets and their estimated useful lives and uses a straight-line method of amortization.

 

   

Estimated fair

value

   

Estimated useful

life in years

   

Twelve months ended

June 30, 2024

amortization expense

 

Customer relationships

  $ 106,300       12     $ 8,858  

Trade names

    28,700    

Indefinite

      -  
                    $ 8,858  

 

(c)

Represents the estimated transaction costs associated with the Amran/Narayan Group acquisition incurred by Standex subsequent to June 30, 2024. These costs will not affect the Company’s income statement beyond 12 months after the acquisition date.

 

(d)

Represents the interest expense (including amortization of loan discount) on the Term Loan Credit Agreement as if the loan was obtained on July 1, 2023 and was outstanding for the entire year ended June 30, 2024. The interest rate assumed for purposes of preparing this pro forma financial information is 7.7% on average. This rate is the daily benchmark rate of 4.82% on October 28, 2024, plus the margins specified in the facility agreement. A 1/8 of a percentage point increase or decrease in the benchmark rate would result in a change in interest expense of approximately $0.3 million for the year ended June 30, 2024.

 

(e)

Represents an adjustment to income tax expense related to the pre-tax pro forma adjustments to the income statement. The tax-related adjustments are based on an estimated tax rate of 22.6%.

 

(f)

Represents the adjustment to reflect the noncontrolling interest holder's proportionate share of 9.9% of each of: (i) Narayan's income from operations for the year ended June 30, 2024 ($0.8 million of the $31.9 million historical Amran/Narayan Group income); and (ii) Narayan's pro forma accounting adjustments ($0.9 million of the $47.5 million transaction accounting adjustments loss). 

 

(g)

Represents the 152,299 shares of Standex common stock issued to the Amran sellers as described in Note 1.

 

8